AI assistant
Sending…
InspireMD, Inc. — Director's Dealing 2023
Mar 1, 2023
34187_dirs_2023-03-01_887b0e51-4776-403a-b4d9-89b028ff353a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2023-03-01
Reporting Person: Gleason Shane Thomas (VP Global Marketing)
More from InspireMD, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 3
Board/Management Information
2026
May 22
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 20
Capital/Financing Update
2026
Apr 3
Capital/Financing Update
2026
Apr 3
Annual Report
2026
Mar 18
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 11
Major Shareholding Notification
2026
Feb 2